- Value investors will be rewarded eventually, David Rosenberg, chief economist and strategist at Rosenberg Research Associates, said in a recent RealVision interview.
- “If we go into a new economic cycle, the value stocks are going to surge,” he said.
- However, Rosenberg predicted they will only skyrocket if there are “sustained signs of inflation, higher rates, a steeper yield curve, and a durable acceleration of global growth.”
- Rosenberg also underscored the appeal of reasonably priced growth stocks when growth is hard to come by, and warned it isn’t sustainable for governments to keep shoring up asset prices with stimulus.
- Visit Business Insider’s homepage for more stories.
Value investors have trailed growth investors in recent years thanks to the outperformance of technology stocks. They will eventually be rewarded for their patience, David Rosenberg, chief economist and strategist at Rosenberg Research Associates, said in a RealVision interview released this week.
“If we go into a new economic cycle, the value stocks are going to surge,” Rosenberg said. “It’s way too early right now but that day is going to come, and you’ll get paid to wait.”
A CIO who earned up to 90% per trade during the March crash offers his 2 best strategies for protecting against Trump-driven volatility â€” and says the president’s diagnosis will be the catalyst for a further sell-off
Value stocks are broadly priced for a prolonged recession, limiting the downside to betting on them, he continued. However, they won’t soar until a few things happen, he cautioned.
“Value is a trade, it’s not yet a trend,” Rosenberg said. “For value to really take over in the stock market, we need to see sustained signs of inflation, higher rates, a steeper yield curve, and a durable acceleration of global growth.”
Still, Rosenberg acknowledged the appeal of reasonably priced growth stocks.
“You want to own these growth stocks because of scarcity of growth,” he said. “You want to own what’s scarce,” he continued, adding that yield is also hard to come by.
In other words, growth stocks look attractive when few companies are growing and cash and bonds are yielding almost nothing due to rock-bottom interest rates.
However, Rosenberg warned that asset prices are being buoyed by unprecedented, unsustainable levels of monetary and fiscal stimulus in response to the pandemic.
“The medication provided by the doctor was more than double the actual pain that the patients received,” he said, referring to authorities flooding the US economy with $US5 trillion of stimulus in response to a $US2 trillion loss of GDP.
Business Insider Emails & Alerts
Site highlights each day to your inbox.